Processus Dégénératifs, Stress et Vieillissement

Contrats récents

 

2017-2019 – Association AFAF – Identification de stratégies thérapeutiques dans de nouveaux modèles Drosophiles de l’ataxie de Friedrich à expansions GAA.

2016-2019 – Infinitus – Infinitus Society Research Project.

2016-2017 – FEANS – Validation of Dyrk1A as a biomarker for Alzheimer’s disease.

2016 – Association TRT2.1 – Development of inhibitors of cystathionine beta synthase.

2016-2017 – Institut Jérôme Lejeune – Biomarker analysis of the action of EGCG in mice.

2014-2016 – Fondation Jérôme Lejeune – Potential correction of molecular and cognitive impairments in a model of hyperhomocysteinemia due to cystathionine beta synthase deficiency.

2014-2016 – Fondation Jérôme Lejeune – DYRK1A dosage can act on metabolic pathways involved in Alzheimer’s disease in Trisomy 21.

2014-2016 – Friedreich Ataxia Research Alliance – Identification of therapeutic compounds on a cardiac Drosophila model of Friedreich’s ataxia.

2013-2016 – Association Lagafe – New therapeutic approach for cardiac and neuromuscular disorders in homocystinuria.

2012-2017 – Association ANR – Fighting Friedreich’s Ataxia.

2012-2016 – AFRT – Research on Trisomy 21.